RECORDS ARE PUBLISHED REGULATORY ACTIONS. FIELDS THE ISSUING AUTHORITY DID NOT PUBLISH ARE MARKED AS NOT STATED, NEVER FILLED IN.
Drug Eye AfricaNational Actions, Continental Reach
Register / Egypt / DEA-EG-2022-0029
Egyptian Drug Authority · Egypt
DEA-EG-2022-0029
Tier 1 · Regulator-publishedUnclassifiedPublic warningStatus · active
Issuing authority
Egyptian Drug Authority (EDA)
Authority reference
Periodic report no.(29) For 2022
Date issued
25 Oct 2022
Recorded by us
2026-09-06 19:45:29 UTC
Product
Restylane Lyft Lidocaine
INN / active substance
Not stated by the issuing authority
Dosage form
Not stated by the issuing authority
Strength
Not stated by the issuing authority
Manufacturer
Not stated by the issuing authority
Manufacturer country
Not stated by the issuing authority
MAH or importer
Not stated by the issuing authority
Batch numbers
Not published with the notice
Expiry dates
Not published with the notice
Action type
Public warning
Classification
Not stated by the issuing authority
Indicative severity
Not assessed by Drug Eye Africa
Defect category
Not stated by the issuing authority
Product type
Not stated by the issuing authority
ATC code
Not stated by the issuing authority
Affected markets
Egypt — no market beyond the issuing country was named on the notice
Cross-border event
Not linked to a cross-border event
Notice text
@egyptiandrugauthority www.edaegypt.gov.eg 15301 ٥٢ أكتوبر٢٢٠٢ يتم ضبط وتحريز العبوات المقلدة من المستلزمات التالية: Restylane Lyft Lidocaine Ref: 011341 Lot: 16787- 9 Exp:19- 12 - 2023 حيث يمكن التفرقة ظاهرياً بين العبوات الأصلية والعبوات المقلدة للمستلزم المذكور -وذلك بناءً على ماورد إلينا من الشركة صاحبة المستلزم- كالآتي: منشور غش تجاري حيث إنه بناء على ما ورد إلينا من الشركة صاحبة المستلزم فإن كل العبوات المدون عليها كلا من ذلك المستلزم 19-12-2023 وكذا تاريخ انتهاء الصلاحيةLot: 16787- 9من رقم مقلدة ولا تخص الشركة . @egyptiandrugauthority www.edaegypt.gov.eg 15301 Restylane Lyft Lidocaine Ref: 011341 Lot: 16787- 9 Exp:19- 12 - 2023 @egyptiandrugauthority www.edaegypt.gov.eg 15301 ٥٢ أكتوبر٢٢٠٢ يتم ضبط وتحريز العبوات المقلدة من المستلزمات التالية: Restylane Lidocaine Ref: 011341 Lot: 16787- 9 Exp:15- 11 - 2023 حيث يمكن التفرقة ظاهرياً بين العبوات الأصلية والعبوات المقلدة للمستلزم المذكور -وذلك بناءً على ماورد إلينا من الشركة صاحبة المستلزم- كالآتي: منشور غش تجاري حيث إنه بناء على ما ورد إلينا من الشركة صاحبة المستلزم فإن كل العبوات المدون عليها كلا من ذلك المستلزم 15-11-2023 وكذا تاريخ انتهاء الصلاحيةLot: 16787- 9من رقم مقلدة ولا تخص الشركة . @egyptiandrugauthority www.edaegypt.gov.eg 15301 Restylane Lidocaine Ref: 011341 Lot: 16787- 9 Exp:15- 11 - 2023
Original language: ar
Notice text in English
Trade-counterfeiting circular, October 2022. Counterfeit packs of the following medical device are to be impounded and seized: Restylane Lyft Lidocaine, reference 011341, lot 16787-9, expiry 19-12-2023. Genuine and counterfeit packs can be told apart by sight, on the basis of what the company that owns the device has reported to the Authority.
Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
Status
Active
Superseded by
Not superseded. This is the current version.
Version
1

Provenance

Verification tier 1

Where this record came from, and what is held to show it.

Primary source
https://www.edaegypt.gov.eg/media/rayl2di5/%D9%85%D9%86%D8%B4%D9%88%D8%B1-%D8%AF%D9%88%D8%B1%D9%8A-%D8%B1%D9%82%D9%85-29-%D9%84%D8%B3%D9%86%D8%A9-2022.pdf
Copy of the source
Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.
Ask us for it and check it against the fingerprint below.
Fingerprint
01868b83089eda5bf09f72082bab50c8233fd87e869fb883debe94fe776e4587
SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
Copy taken
2026-09-06 20:36:21 UTC
Cite this record
Drug Eye Africa (2022). DEA-EG-2022-0029: Restylane Lyft Lidocaine — Public warning, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2022/dea-eg-2022-0029

Version history

—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.

Verification

Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.

Indexing

This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.

This record as data

/api/v1/notices/DEA-EG-2022-0029